Check out today’s featured companies who have recently raised a round of funding, and be sure to check out the full list of past healthcare IT fundings.
Luminai Raises $38 Million Series B to Scale Intelligence Across Health System Operations
Luminai, an AI-native enterprise automation platform purpose-built for healthcare operations, today announced the close of a $38 million Series B funding round, bringing total capital raised to $60 million. The round was led by Peak XV Partners (formerly Sequoia India & Southeast Asia), with participation from new investor Define Ventures and continued backing from existing investors, including General Catalyst and Y Combinator.
The financing will accelerate Luminai’s growth as large provider organizations look for scalable ways to modernize administrative work amid mounting cost pressure, staffing constraints, and increasing operational complexity.
“What stands out about Luminai is their platform approach to a historically fragmented problem. While most vendors optimize individual tasks and point solutions, Luminai is building the intelligent orchestration layer that will define how healthcare operations function in the future,” said Shailendra Singh, Managing Partner at Peak XV Partners. “Their engineering rigor and customer-embedded execution model position them to become foundational infrastructure as health systems fundamentally rethink how operational work gets done.”
Across the industry, provider organizations are contending with fragmented information flows, aging technology stacks, and labor-intensive processes that introduce cost, delay, and risk. Administrative activity is estimated to account for up to 25% of total healthcare spending. Much of that burden is driven by work that spans disconnected systems and depends on manual interpretation of unstructured information. In response, many organizations are moving beyond narrow point solutions toward adaptable platforms that can support a range of high-impact use cases over time.
“Healthcare’s administrative functions operate as a massive, manual coordination layer. Encoding that work into software has historically been difficult because workflows span systems and point solutions, depend on unstructured inputs, and require embedded business and clinical context at every step,” said Kesava Kirupa Dinakaran, Founder and CEO at Luminai…
Full release here, originally announced April 9th, 2026.
Remission Medical Closes Series A Led by Blue Heron Capital to Expand Virtual Rheumatology Partnerships Across U.S. Health Systems
Investment Accelerates the Company’s Proven Model of Embedding Specialty Care Directly Inside Health System Operations, Now Active Across Major Health System Partners and Backed by an AI-Native Workforce Platform Built to Scale
Remission Medical, Inc., a virtual rheumatology company that contracts directly with health systems to deliver embedded specialty care, today announced the close of a Series A funding round led by Blue Heron Capital, an early-stage growth equity firm. The investment will fuel expansion of the company’s partner network, grow its clinical workforce, and accelerate the scaling infrastructure that allows Remission Medical to rapidly deploy rheumatology access across more systems, more markets, and ultimately more specialties.
Rheumatic diseases, including rheumatoid arthritis, lupus, and psoriatic arthritis, affect more than 54 million Americans. Yet the United States faces a severe and worsening shortage of rheumatologists, leaving patients waiting an average of more than two months for a first specialist appointment. For health systems, this gap translates directly into lost referrals, declining quality scores, and patients who go undiagnosed or undertreated for conditions that are highly manageable when caught early.
Remission Medical solves this through a turnkey partnership model. The company embeds highly credentialed Advanced Practice Providers (APPs) directly inside health system infrastructure, operating under existing EMR workflows, payer contracts, and clinical protocols, so health systems can stand up a functioning rheumatology service line in weeks rather than years. Critically, what enables Remission Medical to deploy this model at scale across a growing national network is RemissionOS (ROS), the company’s proprietary AI-native workforce platform.
ROS is purpose-built to manage the complexity of running a distributed clinical workforce across multiple health system environments simultaneously. The platform supports how Remission Medical manages provider capacity, performance, and partner workflows at scale by automating referral intake, clinical scheduling, documentation support, revenue cycle operations, and performance reporting, all calibrated to each partner’s existing EMR and operational protocols. This AI-native operational backbone allows Remission Medical to onboard new health system partners efficiently, maintain quality and consistency across a geographically dispersed provider network, and generate the outcomes data that health systems need to sustain and expand their rheumatology programs internally.
The company currently operates across major health system partners nationwide, including Sentara, OrthoVirginia, WellSpan, Ochsner, Campbell Clinic, Gundersen, MultiCare, and St. Francis, spanning…
Full release here, originally announced April 9th, 2026.
No comments:
Post a Comment